Rankings
▼
Calendar
LIVN Q1 2020 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q1 2020 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$242M
-3.4% YoY
Gross Profit
$171M
70.3% margin
Operating Income
$23M
9.5% margin
Net Income
$38M
15.5% margin
EPS (Diluted)
$0.77
QoQ Revenue Growth
-15.7%
Cash Flow
Operating Cash Flow
-$106M
Free Cash Flow
-$115M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$2.5B
Total Liabilities
$1.1B
Stockholders' Equity
$1.4B
Cash & Equivalents
$126M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$242M
$251M
-3.4%
Gross Profit
$171M
$164M
+4.2%
Operating Income
$23M
-$21M
+210.9%
Net Income
$38M
-$15M
+353.1%
Revenue Segments
Neuromodulation Segment
$90M
78%
Cardiovascular Segment
$25M
22%
Geographic Segments
UNITED STATES
$124M
51%
Locations Excluding The United States And Europe
$64M
26%
Europe
$55M
23%
← FY 2020
All Quarters
Q2 2020 →